Ptns with severe, chronic hypo-Na+ (Na+ <120 mEq/L) and mild/moderate Sms are commonly ttt with either a continuous infusion or intermittent boluses
Intermittent bolus vs continuous infusion
of hypertonic saline in severe hyponatremia (Nov. 2020)
Ptns with severe,
chronic hypo-Na+ (Na+ <120 mEq/L) and mild/moderate Sms are commonly ttt with either a continuous infusion or
intermittent boluses of 3 % saline, but these regimens have not been compared in
a direct fashion. In an un-blinded
trial, nearly 180 such ptns were randomly assigned to continuously infused
(0.5 mL/kg/h) or intermittent boluses
(2 mL/kg/6
hs) of 3 % saline; these doses are currently
higher than recommended. Both regimens, however, were
associated with similar rates of Sms relief & correction rate
of hyponatremia; nevertheless, rates of the rapidly corrected levels were eventually higher, and almost ½ of cases necessitate
intervention to decrease s. Na+ again. Experts
continue endorsing either approach to 3
% saline infusion (continuous infusion or intermittent
boluses) with a more conservative dosage plans to prevent overly rapidly corrected
hypo-
Na+.
Severe
hyponatremia (Na+
<120 mEq/L):
ptn with severe, chronic hypo-Na+ (s.
Na+ <120 mEq/L), require
IV 3 % saline
starting with 0.25 mL/kg/h, infused via a peripheral vein;
use 3 % saline
(rather than normal saline) in ptns with
& without current hypovolemia.
Alternatively, is infusing 1 mL/kg boluses of 3 % saline IV/6 hs
with modifying the dose accordingly as required. However, some ptns may need desmopressin
(dDAVP)
to impede the overly rapid correction.
There is an evidence
that 3 % saline
can be safely infused in a peripheral vein,
but there’s no evidence that it induces > vascular
thrombosis or extravasation injuries. However, some centers’ policies starting
3 % saline
should be ONLY infused via
a central vein.
Such policy urges some clinicians to select only isotonic saline instead of the hypertonic one for hypovolemic ptns; however, isotonic saline should
be completely prohibited
with severe hypo-Na+. If 3 % saline
cannot be provided due to center’s policy restriction, then an infusion of 1.5-2 % saline is
suggested but with a more rapid rate than that given for 3 % saline.
Scarce data declaring
the options among slow, continuous infusion & intermittent boluses of 3
% saline
in severe hypo-Na+ + mild/moderate Sms.
One non blinded trial comparing continuous infusion (0.5 mL/kg/h) with intermittent bolus (s) (2 mL/kg/6 h.s); the dose of 3 % saline are eventually
higher than currently recommended.
The 2 g. (s) had similar results regarding Sm resolution &
overcorrection. However, with these
dosages, therapeutic re-lowering with 5 % dextrose in water was currently needed in about ½ of cases, and
despite this maneuver, overcorrection has been frequently observed. As most ptns were
at very low risk of ODS,
safety of
these protocols is not established yet. With easily reversible
cause (s) of hypo-Na+
(e.g., hypovolemia) and likely to
develop a water diuresis during treatment,
or with higher risk of osmotic demyelination
syndrome (ODS),
simultaneous desmopressin
should be provided to prohibit overly rapid
correction.
Risk factors for ODS include:
1)
Very low Na+ ≤105 mEq/L
2)
Concomitant hypo-k+.
3)
Malnourished
subjects
4)
Chronic excessive alcohol abuse
5)
Acute or chronic liver disorders
Rapidly reversible causes of
hyponatremia include:
1)
Hypo-Na+ related to depleted true volume (corrected hypovolemia will inhibit ADH,
so, >> water diuresis)
2)
Hypo-Na+ related to adrenal
insufficiency (providing adrenal steroids will inhibit ADH & induce water
diuresis)
3)
Hypo-Na+ related to the SIADH; including post-surgical ptns or SIADH related
to painful condition or medications).
Ptns with severe
hypo-Na+ are vulnerable to
more worse Sms if s. Na+ decline
more and, on the other hand, they are at risk of ODS
if s. Na+ corrected very quickly. Ideally, the lower Na+ level,
the greater this risk.
So, it is preferred to give 3
% saline in such ptns to ttt hypo-Na+, even among hypovolemic
ptns. Isotonic saline can be provided concomitantly (with 3 % saline), if required, to control symptomatic hypovolemia or pre-renal azotemia.
COMMENTS